Jaguar Health, Inc. JAGX
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$2.06$2.24
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.23M | 20.25M | 3.24M | 3.08M | 2.98M |
| Total Other Revenue | -- | 25.00K | -- | -- | -- |
| Total Revenue | 1.23M | 20.27M | 3.24M | 3.08M | 2.98M |
| Cost of Revenue | 1.03M | 1.16M | 2.20M | 532.00K | 527.00K |
| Gross Profit | 194.00K | 19.11M | 1.04M | 2.55M | 2.45M |
| SG&A Expenses | 4.46M | 5.00M | 7.16M | 6.13M | 7.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.82M | 10.09M | 23.68M | 10.32M | 10.99M |
| Operating Income | -7.60M | 10.18M | -20.44M | -7.24M | -8.01M |
| Income Before Tax | -12.80M | 8.72M | -23.19M | -9.65M | -10.56M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.80M | 8.72M | -23.19M | -9.65M | -10.56M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 120.00K | 126.00K | 132.00K | 146.00K | 153.00K |
| Net Income | -12.68M | 8.85M | -23.06M | -9.50M | -10.41M |
| EBIT | -7.60M | 10.18M | -20.44M | -7.24M | -8.01M |
| EBITDA | -7.12M | 10.66M | -19.97M | -6.76M | -7.53M |
| EPS Basic | -235.46 | -204.01 | -2.30K | -- | -- |
| Normalized Basic EPS | -105.51 | 173.63 | -1.37K | -- | -- |
| EPS Diluted | -235.46 | -204.01 | -2.30K | -- | -- |
| Normalized Diluted EPS | -105.51 | 173.63 | -1.37K | -- | -- |
| Average Basic Shares Outstanding | 53.90K | 34.40K | 10.10K | -- | -- |
| Average Diluted Shares Outstanding | 53.90K | 34.40K | 10.10K | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |